About TMU


About the President

 Introducing TMU's New President, Prof. Yun Yen

President, Prof. Yun Yen

On Monday, 1 August 2011, Taipei Medical University inaugurated Prof. Yun Yen as its new President. More than 300 participated in this event, including many members of Taiwan’s diplomatic corps, Board Members, Representatives of Alumni Associations, faculties and students, attended a ceremony and reception to welcome the new leader, who comes from the Developmental Cancer Therapeutics Program of the City of Hope Comprehensive Cancer Center in the United States.

A university committee selected Prof. Yen for the post in May, following the appointment of the former TMU president, Prof. Wen-Ta Chiu, to lead Taiwan’s Department of Health. Minister Chiu spoke at the inauguration, as did outgoing Acting President Ching-Hua Su and several other university and community leaders.

In his inaugural speech, Prof. Yen noted that Taipei Medical University recently celebrated its 51st anniversary this year, and he promoted his vision for TMU as increasing quality in research, education, patient care and other areas. His leadership will continue to increase the global influence of TMU, which has grown to become a leading comprehensive medical university with more than 30,000 alumni around the world.

Prof. Yun Yen’s Biography

Prof. Yen received his medical degree from Taipei Medical College in 1982 and his Ph.D. in Pathology and Cell Biology from Thomas Jefferson University in Philadelphia, Pennsylvania, in the United States in 1987. Following residency training at St. Luke's Hospital, which is affiliated with Temple University, Prof. Yen completed a fellowship in the Department of Internal Medicine, Hematology and Bone Marrow Transplantation and Oncology Section at Yale University’s School of Medicine. Subsequently, he joined City of Hope in 1993 as a staff physician. He is currently a professor in Medical Oncology and the Graduate School of Biological Sciences, as well as chief of Biochemical Pharmacology in the Department of Medical Oncology and Therapeutics Research.

Among Prof. Yen’s grant awards are several from the U.S. National Institutes of Health, including a prestigious predoctoral fellowship training grant while at Thomas Jefferson University and a K12 training grant while at City of Hope. In addition, he has been awarded U.S. Army grants to research breast and prostate cancers. The National Cancer Institute’s Cancer Therapy Evaluation Program has designated his laboratory the ribonucleotide reductase real-time PCR reference laboratory.

Prof. Yen holds membership in numerous professional organizations, including the American Association for the Advancement of Science, the American Society of Clinical Oncology, Sigma-Xi Scientific Association and the New York Academy of Sciences. He has published more than 140 abstracts and peer-reviewed journal articles, and he serves as an ad-hoc reviewer and referee for several journals and as a Journal of Clinical Colorectal Cancer editorial board member. As a highly experienced clinician, clinical investigator and basic scientist, Prof. Yen’s research interests focus on several markers of hepatocellular cancer, as well as on investigational therapies for advanced malignancy.

The university community welcomes his leadership, which will provide new ideas for the next half-century of TMU’s progress in the world.

  • Decorative image
    Sorbonne's Lutomski speaks on proteomics 20 Sept.


cron web_use_log